Bicycle Therapeutics (BCYC) Deferred Taxes (2022 - 2026)

Bicycle Therapeutics (BCYC) has 5 years of Deferred Taxes data on file, last reported at $326000.0 in Q2 2026.

• Quarterly Deferred Taxes rose 198.49% year-over-year to $326000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $428000.0 (up 107.14% YoY) and the FY2025 annual result came in at -$1.3 million, up 75.05% from the prior year.
• Deferred Taxes rose to $326000.0 in Q2 2026, from -$241000.0 in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $7.3 million in Q3 2023 to a low of -$3.3 million in Q3 2024.
• A 5-year average of -$450833.3 and a median of -$757500.0 in 2022 frame the typical range for Deferred Taxes.
• Annual changes were most pronounced in 2023 — Deferred Taxes jumped 810.06% — and 2024, when it tumbled 266.67%.
• Tracing BCYC's Deferred Taxes over 5 years: stood at -$2.3 million in 2022, then surged by 87.93% to -$282000.0 in 2023, then plunged by 266.67% to -$1.0 million in 2024, then surged by 137.62% to $389000.0 in 2025, then declined by 16.2% to $326000.0 in 2026.
• The last three Deferred Taxes figures came in at $326000.0 (Q2 2026), -$241000.0 (Q1 2026), and $389000.0 (Q4 2025), per Business Quant data.